America's first independent biomedical research institute (1892), an NCI basic cancer centre known for melanoma biology, monoclonal antibodies and DNA vaccines.
The Wistar Institute, founded in 1892 on the University of Pennsylvania campus, has held NCI basic laboratory designation since 1972. Hilary Koprowski and Zenon Steplewski's 17-1A antibody (edrecolomab) was among the first monoclonal antibodies tested in cancer patients; Meenhard Herlyn built one of the world's leading melanoma biology programmes and 3D skin and tumour models; David Weiner pioneered DNA vaccines, including candidates for glioblastoma; Rugang Zhang identified the ARID1A-EZH2 synthetic lethality in ovarian clear-cell carcinoma. President Dario Altieri studies survivin and mitochondrial signalling. Wistar has no clinic and translates through Penn, Jefferson, Fox Chase and industry partners.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to The Wistar Institute, including child institutions. 287 works · 3,352 citations · 69% open access · 7% clinical trials · 2% reviews.
Shares NCI-Designated Cancer Centers, Lab models that fail to predict what happens in patients, National Cancer Institute (NIH), Glioma & glioblastoma.
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH), Glioma & glioblastoma, Ovarian cancer.
Shares NCI-Designated Cancer Centers, Off-the-shelf cancer vaccines, National Cancer Institute (NIH), Melanoma.
Shares NCI-Designated Cancer Centers, National Cancer Institute (NIH), Monoclonal antibodies, Melanoma.
Shares Lab models that fail to predict what happens in patients, National Cancer Institute (NIH), Glioma & glioblastoma.
Shares NCI-Designated Cancer Centers, Lab models that fail to predict what happens in patients, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, Lab models that fail to predict what happens in patients, National Cancer Institute (NIH).
Shares NCI-Designated Cancer Centers, Lab models that fail to predict what happens in patients, National Cancer Institute (NIH).